| Title : Pediatric phase I trial design using maximum target inhibition as the primary endpoint - Meany_2010_J.Natl.Cancer.Inst_102_909 |
| Author(s) : Meany H , Balis FM , Aikin A , Whitcomb P , Murphy RF , Steinberg SM , Widemann BC , Fox E |
| Ref : J Natl Cancer Inst , 102 :909 , 2010 |
| Abstract : |
| PubMedSearch : Meany_2010_J.Natl.Cancer.Inst_102_909 |
| PubMedID: 20460632 |
| Title : Pediatric phase I trial design using maximum target inhibition as the primary endpoint - Meany_2010_J.Natl.Cancer.Inst_102_909 |
| Author(s) : Meany H , Balis FM , Aikin A , Whitcomb P , Murphy RF , Steinberg SM , Widemann BC , Fox E |
| Ref : J Natl Cancer Inst , 102 :909 , 2010 |
| Abstract : |
| PubMedSearch : Meany_2010_J.Natl.Cancer.Inst_102_909 |
| PubMedID: 20460632 |
| Title : Pediatric phase I trial design using maximum target inhibition as the primary endpoint - Meany_2010_J.Natl.Cancer.Inst_102_909 |
| Author(s) : Meany H , Balis FM , Aikin A , Whitcomb P , Murphy RF , Steinberg SM , Widemann BC , Fox E |
| Ref : J Natl Cancer Inst , 102 :909 , 2010 |
| Abstract : |
| PubMedSearch : Meany_2010_J.Natl.Cancer.Inst_102_909 |
| PubMedID: 20460632 |